Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FDOPA PET in Gliomas
NCT02175745Terminated
- Start
- Dec 2014
- Primary completion
- Aug 2015
- Countries
- 1
01
Overview
Open-label, single-arm trial. Primary endpoints: Number of Suspicious Lesions Identified by 18F FDOPA PET at 30 months and Percent Agreement of 18F FDOPA PET With Pathology at 30 months. Started Dec 2014; status: terminated.
Beyond the preview
Go deeper on NCT02175745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175745.